Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Tumor-Infiltrating Lymphocytes. Found 5 abstracts

Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SS. Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199. Journal of Clinical Oncology. 2014 Sep;32(27):2959-66.   PMCID: 4162494
Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM, Perlis CS, Turaka A. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma. J Am Acad Dermatol. 2014 Jun;70(6):1028-35.   PMCID: No NIH funding
Mantia-Smaldone G, Ronner L, Blair A, Gamerman V, Morse C, Orsulic S, Rubin S, Gimotty P, Adams S. The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1--deficient ovarian tumors and can be exploited to improve treatment response in a mouse model. Gynecol Oncol. 2014 Jun;133(3):584-90.
Milling SW, Sai T, Silvers WK, Mintz B. Inhibition of melanoma growth after treatment with dendritic cells in a Tyr-SV40E murine model requires CD4+ T cells but not CD8+ T cells. Melanoma Research. 2004 Dec;14(6):555-62.
Zhang H, Merchant MS, Chua KS, Khanna C, Helman LJ, Telford B, Ward Y, Summers J, Toretsky J, Thomas EK, June CH, Mackall CL. Tumor expression of 4-1BB ligand sustains tumor lytic T cells. Cancer Biol Ther. 2003 Sep;2(5):579-86.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Tumor-Infiltrating Lymphocytes

Tumor-Infiltrating Lymphocytes Female Mice Adult immunology Aged 80 and over Aged Dendritic Cells Male Prognosis Cytotoxic T-Lymphocytes Comparative Study Middle Aged Disease-Free Survival T-Lymphocytes Skin Neoplasms Retrospective Studies pathology Risk Assessment Proportional Hazards Models immune function Tumor Biomarkers Animal Disease Models prevention & control Tumor Cell Line Randomized Controlled Trials as Topic Macrophages Transgenic Mice pa [Pathology] therapy bl [Blood] Polyethylene Glycols Immunomodulation genetics skin cancer th [Therapy] analogs & derivatives Brca Tumor Necrosis Factor 0 (Neoplasm Proteins) im [Immunology] Lymphocyte Count Neoplasm Proteins 0 (Immunoglobulin G) Lymphocyte Activation drug effects Cultured Cells CD3 Antigens blood Experimental Melanoma CD8 Antigens Survival Analysis Reproducibility of Results CD4-Positive T-Lymphocytes Combined Modality Therapy Regression Analysis 0 (Peptide Fragments) 0 (Cytokines) pharmacology Antigen Receptors-T-Cell Simian virus 40 Ovarian cancer Merkel cell carcinoma methods Inbred C57BL Mice Phase III Clinical Trials as Topic Immunoglobulin G Triple Negative Breast Neoplasms ge [Genetics] Cell Survival me [Metabolism] Antineoplastic Antibiotics Human Monophenol Monooxygenase Cohort Studies Ligands Adolescent Immunologic Cytotoxicity Tests Xenograft Model Antitumor Assays Predictive Value of Tests Kaplan-Meier Estimate Ovarian Neoplasms absolute lymphocyte count Bone Neoplasms SCID Mice Antineoplastic Combined Chemotherapy Protocols Ewing's Sarcoma EC 1-14-18-1 (Monophenol Monooxygenase) BRCA1 Genes metabolism Biological Markers skin neoplasm Adjuvant Chemotherapy Cytokines Non-US Gov't Support analysis Doxorubicin Neoplasm Invasiveness Multivariate Analysis Host immunity CD28 Antigens T cells Non-US Gov't Research Support Peptide Fragments CD8-Positive T-Lymphocytes 0 (Melan-A protein) drug therapy Neoplasm Staging therapeutic use Pegylated Liposomal Doxorubicin mortality Merkel Cell Carcinoma Cell Proliferation
Last updated on Wednesday, February 05, 2020